Exact Sciences
GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing
SomaLogic, Exact Sciences, and Myriad paced the winners in January, while Olink, a new addition to the Top 40, led decliners.
JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More
Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.
Exact Sciences Projects 28 Percent Bump in Total Q4 Oncology Revenue
The company expects to report consistent growth in both cancer screening and precision oncology testing for the quarter and the full fiscal year.
GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq fell 9 percent, and the Nasdaq Biotech Index was down 3 percent.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.